AlphaYouMM
Insider selling
Masaru Matsuda sold $92K of Arcutis Biotherapeutics, Inc. (ARQT) stock
Masaru Matsuda sold 3,674 shares of ARQT stock worth $92K, per an SEC Form 4 filed Sep 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 16, 2026, 2 days before it was made public.
ARQT has moved +6.3% since the trade date, from $26.14 to $27.78 (Sep 22, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 18, 2026
- Filing delay
- 2 days
- Price since
- +6.3%
- Source
- SEC Form 4
More ARQT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.